Examination Report |
1 | TM-1 | 13 Aug 2014 |
2 | Authorization Document (POA) | 13 Aug 2014 |
3 | Reply to Exam Report (MIS-R) | 18 Feb 2016 |
4 | Reply to Exam Report (MIS-R) | 28 Sep 2018 |
5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 26 Oct 2018 |
6 | Journal Copy | 24 Jan 2019 |
7 | Certificate | 22 Mar 2019 |
8 | TM-R(RENEWAL OF TRADE MARK) | 12 Aug 2024 |
1 | Hearing Notice (Show Cause) | 6662261 | 3031521 | 13 Jul 2018 |
2 | Tribunal Accepted Notice for : 2790949 | 7191387 | 3345074 | 26 Oct 2018 |
3 | O3 NOTICE | 18418300 | 6796568 | 01 Jul 2024 |
4 | RENEWAL INTIMATION LETTER | 18698633 | 15 Aug 2024 |
Trademark was applied on 13 August 2014 with IP India.
Proprietor of Dughdam is TRIVET PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 31.
Status of Dughdam is Registered.
Application number alloted to the trademark is 2790949.
Lalji Advocates is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD